The Big Health Care Conundrum: How To Sustainably Unlock The Value Of Diagnostics
Novo holdings panel asks diagnostics industry leaders how to keep the focus on testing post-pandemic
How can stakeholders capitalize on this moment of acute public awareness of diagnostics to improve adoption of tests and screening in the long term? At a recent roundtable event, the CEOs of Roche Diagnostics, GE Healthcare, Labcorp and Synlab, among others, gave their thoughts on how the system must change.
You may also be interested in...
The Swiss company is preparing for a smooth transition in 2023, appointing 20-year Roche veteran and diagnostic chief Thomas Schinecker as its next chief executive as Severin Schwan becomes chairman.
The trend among device innovators to focus on diagnostic technologies that improve imaging, offer better visualization of tissues and avoid the need for biopsies is well noted by full-service law firm CMS. Its equIP program supports many start-ups incorporating AI into products and development processes.
Forum officially unveiled on 19 February to represent growing band of organizations designated against the UKCA mark.